Overview

This trial is active, not recruiting.

Conditions hiv positive, marijuana smoking
Sponsor Wayne State University
Collaborator National Institute on Drug Abuse (NIDA)
Start date February 2012
End date June 2017
Trial size 150 participants
Trial identifier NCT01536899, MMC-1, R01DA032678

Summary

The investigators are interested in understanding personal factors such as medical conditions and mental health, as well as social and economic factors, that influence marijuana (and other substance) use in HIV-positive patients.

Several alternative hypotheses will be evaluated in the proposed project:

1. healthier patients may self-select marijuana use;

2. marijuana use may be associated with consequences that create barriers to seeking healthcare;

3. marijuana use may have medicinal value that reduces the need for such care.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective

Eligibility Criteria

Male or female participants from 18 years up to 70 years old.

Inclusion Criteria: - Participants will be patients in the HIV clinic. - Participants will have HIV. - Participants will sign a single consent form. - Participants will be marijuana users. Exclusion Criteria: - Participants who test negative for marijuana will be excluded. - Volunteers who exhibit signs of drug intoxication or cognitive/mental impairment during the consent process will be excluded.

Additional Information

Official title Behavioral Economic Analysis of Medical Marijuana Use in HIV+ Patients Prospective Cohort Study
Principal investigator Mark Greenwald, PhD
Description The study will involve a total of 5 interviews with clinical research staff members, the total involvement will be for about 1 year. The first interview will establish a baseline of current behaviors and health status; this will take about 3-4 hours. This interview will take place at the Tolan Park Medical Building, located at 3901 Chrysler Service Dr. The remaining 4 interviews - which will be shorter in length - will be conducted about 3, 6, 9, and 12 months after the baseline interview; each follow-up interview will take about 2 hours.The purpose of the 4 remaining interviews is to assess changes in behaviors and health status over time. We will collect urine samples at each of the 5 interview sessions to assess health and illicit drug use.
Trial information was received from ClinicalTrials.gov and was last updated in November 2016.
Information provided to ClinicalTrials.gov by Wayne State University.